MA11.06 A PII Study of Toripalimab, a PD-1 mAb, in Combination with Chemotherapy in EGFR+ Advanced NSCLC Patients Failed to Prior EGFR TKI Therapies

Authors:
  • JZJ. Zhang
    J. Zhang
  • CZC. Zhou
    C. Zhou
  • YZY. Zhao
    Y. Zhao
  • XMX. Mu
    X. Mu
  • JZJ. Zhou
    J. Zhou
  • ZBZ. Bao
    Z. Bao
  • YFY. Fan
    Y. Fan
  • YXY. Xu
    Y. Xu
  • YSY. Shu
    Y. Shu
  • RGR. Guo
    R. Guo
  • XLX. Liu
    X. Liu
  • HWH. Wang
    H. Wang

Abstract
No abstract available